APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Bacterial Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Bacterial Vaccine Industry Growth and Trends Forecast to 2032

31 December 202587 pages

Choose your research edition.

Industry ResearchHuman Bacterial Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Bacterial Vaccine Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Human Bacterial Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Bacterial Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Bacterial Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Human Bacterial Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Bacterial Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Bacterial Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Bacterial Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Human Bacterial Vaccine market include Emergent BioSolutions, Mitsubishi Tanabe Pharma, Bayer, GSK, Pfizer, Merck and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Bacterial Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Bacterial Vaccine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Bacterial Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Bacterial Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Human Bacterial Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Bacterial Vaccine Market by Company

Emergent BioSolutions

Mitsubishi Tanabe Pharma

Bayer

GSK

Pfizer

Merck

Sanofi

Human Bacterial Vaccine Segment by Type

Bacillus Anthracis

Haemophilus Influenzae

Salmonella Typhi

Clostridium Tetani

Streptococcus Pneumoniae

Pertussis

Others

Human Bacterial Vaccine Segment by Application

Elderly

Children

Adults

Human Bacterial Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Bacterial Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Bacterial Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Bacterial Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Human Bacterial Vaccine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Human Bacterial Vaccine Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Human Bacterial Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Human Bacterial Vaccine Market Share by Region (2021-2026) Table 4. Global Human Bacterial Vaccine Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Human Bacterial Vaccine Market Share by Region (2027-2032) Table 6. Global Human Bacterial Vaccine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Human Bacterial Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Human Bacterial Vaccine Market Size Share by Type (2021-2026) Table 9. Global Human Bacterial Vaccine Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Human Bacterial Vaccine Market Size Share Forecasted by Type (2027-2032) Table 11. North America Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Human Bacterial Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Human Bacterial Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Human Bacterial Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Human Bacterial Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Human Bacterial Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Human Bacterial Vaccine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Human Bacterial Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Human Bacterial Vaccine Market Size Share by Application (2021-2026) Table 24. Global Human Bacterial Vaccine Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Human Bacterial Vaccine Market Size Share Forecasted by Application (2027-2032) Table 26. North America Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Human Bacterial Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Human Bacterial Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Human Bacterial Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Human Bacterial Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Human Bacterial Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Human Bacterial Vaccine Industry Trends Table 37. Human Bacterial Vaccine Industry Drivers Table 38. Human Bacterial Vaccine Industry Opportunities and Challenges Table 39. Human Bacterial Vaccine Industry Restraints Table 40. Global Human Bacterial Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Human Bacterial Vaccine Revenue Market Share by Company (2021-2026) Table 42. Global Human Bacterial Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Human Bacterial Vaccine Key Company Headquarters & Area Served Table 44. Global Human Bacterial Vaccine Company, Product Type & Application Table 45. Global Human Bacterial Vaccine Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Human Bacterial Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Emergent BioSolutions Company Information Table 49. Emergent BioSolutions Business Overview Table 50. Emergent BioSolutions Human Bacterial Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Emergent BioSolutions Human Bacterial Vaccine Product Portfolio Table 52. Emergent BioSolutions Recent Development Table 53. Mitsubishi Tanabe Pharma Company Information Table 54. Mitsubishi Tanabe Pharma Business Overview Table 55. Mitsubishi Tanabe Pharma Human Bacterial Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Mitsubishi Tanabe Pharma Human Bacterial Vaccine Product Portfolio Table 57. Mitsubishi Tanabe Pharma Recent Development Table 58. Bayer Company Information Table 59. Bayer Business Overview Table 60. Bayer Human Bacterial Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bayer Human Bacterial Vaccine Product Portfolio Table 62. Bayer Recent Development Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Human Bacterial Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GSK Human Bacterial Vaccine Product Portfolio Table 67. GSK Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Human Bacterial Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer Human Bacterial Vaccine Product Portfolio Table 72. Pfizer Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Human Bacterial Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Merck Human Bacterial Vaccine Product Portfolio Table 77. Merck Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Human Bacterial Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Sanofi Human Bacterial Vaccine Product Portfolio Table 82. Sanofi Recent Development Table 83. North America Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. North America Human Bacterial Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 85. North America Human Bacterial Vaccine Market Share by Country (2021-2026) Table 86. North America Human Bacterial Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. North America Human Bacterial Vaccine Market Share Forecast by Country (2027-2032) Table 88. Europe Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Europe Human Bacterial Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 90. Europe Human Bacterial Vaccine Market Share by Country (2021-2026) Table 91. Europe Human Bacterial Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Europe Human Bacterial Vaccine Market Share Forecast by Country (2027-2032) Table 93. Asia-Pacific Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Asia-Pacific Human Bacterial Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 95. Asia-Pacific Human Bacterial Vaccine Market Share by Country (2021-2026) Table 96. Asia-Pacific Human Bacterial Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Asia-Pacific Human Bacterial Vaccine Market Share Forecast by Country (2027-2032) Table 98. Latin America Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Latin America Human Bacterial Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 100. Latin America Human Bacterial Vaccine Market Share by Country (2021-2026) Table 101. Latin America Human Bacterial Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Latin America Human Bacterial Vaccine Market Share Forecast by Country (2027-2032) Table 103. Middle East & Africa Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Middle East & Africa Human Bacterial Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 105. Middle East & Africa Human Bacterial Vaccine Market Share by Country (2021-2026) Table 106. Middle East & Africa Human Bacterial Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Middle East & Africa Human Bacterial Vaccine Market Share Forecast by Country (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Human Bacterial Vaccine Product Image Figure 3. Global Human Bacterial Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Human Bacterial Vaccine Market Size (2021-2032) & (US$ Million) Figure 5. Global Human Bacterial Vaccine Market Share by Region: 2025 VS 2032 Figure 6. Global Human Bacterial Vaccine Market Share by Region (2021-2032) Figure 7. North America Human Bacterial Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Human Bacterial Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Human Bacterial Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Human Bacterial Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Human Bacterial Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Bacillus Anthracis Image Figure 13. Global Bacillus Anthracis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Haemophilus Influenzae Image Figure 15. Global Haemophilus Influenzae Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Salmonella Typhi Image Figure 17. Global Salmonella Typhi Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Clostridium Tetani Image Figure 19. Global Clostridium Tetani Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Streptococcus Pneumoniae Image Figure 21. Global Streptococcus Pneumoniae Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Pertussis Image Figure 23. Global Pertussis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Others Image Figure 25. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Global Human Bacterial Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 27. Global Human Bacterial Vaccine Market Share by Type 2025 VS 2032 Figure 28. North America Human Bacterial Vaccine Market Size Share by Type (2021-2032) Figure 29. Europe Human Bacterial Vaccine Market Size Share by Type (2021-2032) Figure 30. Asia-Pacific Human Bacterial Vaccine Market Size Share by Type (2021-2032) Figure 31. Latin America Human Bacterial Vaccine Market Size Share by Type (2021-2032) Figure 32. Middle East and Africa Human Bacterial Vaccine Market Size Share by Type (2021-2032) Figure 33. Elderly Image Figure 34. Global Elderly Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Children Image Figure 36. Global Children Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Adults Image Figure 38. Global Adults Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Human Bacterial Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Human Bacterial Vaccine Market Share by Application 2025 VS 2032 Figure 41. North America Human Bacterial Vaccine Market Size Share by Application (2021-2032) Figure 42. Europe Human Bacterial Vaccine Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Human Bacterial Vaccine Market Size Share by Application (2021-2032) Figure 44. Latin America Human Bacterial Vaccine Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Human Bacterial Vaccine Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Human Bacterial Vaccine Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Human Bacterial Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Human Bacterial Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Human Bacterial Vaccine Market Share by Country (2021-2032) Figure 51. Europe Human Bacterial Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Human Bacterial Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Human Bacterial Vaccine Market Share by Country (2021-2032) Figure 54. Asia-Pacific Human Bacterial Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Human Bacterial Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Human Bacterial Vaccine Market Share by Country (2021-2032) Figure 57. Latin America Human Bacterial Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Human Bacterial Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Human Bacterial Vaccine Market Share by Country (2021-2032) Figure 60. Middle East & Africa Human Bacterial Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Human Bacterial Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Human Bacterial Vaccine Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Bacillus Anthracis
  • Haemophilus Influenzae
  • Salmonella Typhi
  • Clostridium Tetani
  • Streptococcus Pneumoniae
  • Pertussis
  • Others
Applications
  • Elderly
  • Children
  • Adults
Companies covered
  • Emergent BioSolutions
  • Mitsubishi Tanabe Pharma
  • Bayer
  • GSK
  • Pfizer
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Human Bacterial Vaccine Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Human Bacterial Vaccine Market Size by Region (2021-2032)
  5. 1.4.1 Global Human Bacterial Vaccine Market Size by Region (2021-2026)
  6. 1.4.2 Global Human Bacterial Vaccine Market Size by Region (2027-2032)
  7. 1.5 Key Regions Human Bacterial Vaccine Market Size (2021-2032)
  8. 1.5.1 North America Human Bacterial Vaccine Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Human Bacterial Vaccine Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Human Bacterial Vaccine Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Human Bacterial Vaccine Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Human Bacterial Vaccine Market Size Growth Rate (2021-2032)
2 Human Bacterial Vaccine Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Bacillus Anthracis
  3. 2.1.2 Haemophilus Influenzae
  4. 2.1.3 Salmonella Typhi
  5. 2.1.4 Clostridium Tetani
  6. 2.1.5 Streptococcus Pneumoniae
  7. 2.1.6 Pertussis
  8. 2.1.7 Others
  9. 2.2 Global Human Bacterial Vaccine Market Size by Type
  10. 2.2.1 Global Human Bacterial Vaccine Market Size Overview by Type (2021-2032)
  11. 2.2.2 Global Human Bacterial Vaccine Historic Market Size Review by Type (2021-2026)
  12. 2.2.3 Global Human Bacterial Vaccine Market Size Forecasted by Type (2027-2032)
  13. 2.3 Global Human Bacterial Vaccine Market Size by Regions
  14. 2.3.1 North America Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026)
  15. 2.3.2 Europe Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026)
  16. 2.3.3 Asia-Pacific Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026)
  17. 2.3.4 South America Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026)
  18. 2.3.5 Middle East and Africa Human Bacterial Vaccine Market Size Breakdown by Type (2021-2026)
3 Human Bacterial Vaccine Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Elderly
  3. 3.1.2 Children
  4. 3.1.3 Adults
  5. 3.2 Global Human Bacterial Vaccine Market Size by Application
  6. 3.2.1 Global Human Bacterial Vaccine Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Human Bacterial Vaccine Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Human Bacterial Vaccine Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Human Bacterial Vaccine Market Size by Regions
  10. 3.3.1 North America Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Human Bacterial Vaccine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Human Bacterial Vaccine Industry Trends
  2. 4.2 Human Bacterial Vaccine Industry Drivers
  3. 4.3 Human Bacterial Vaccine Industry Opportunities and Challenges
  4. 4.4 Human Bacterial Vaccine Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Human Bacterial Vaccine Revenue (2021-2026)
  2. 5.2 Global Human Bacterial Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Human Bacterial Vaccine Key Company Headquarters & Area Served
  4. 5.4 Global Human Bacterial Vaccine Company, Product Type & Application
  5. 5.5 Global Human Bacterial Vaccine Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Human Bacterial Vaccine Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Human Bacterial Vaccine Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Human Bacterial Vaccine Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Emergent BioSolutions
  2. 6.1.1 Emergent BioSolutions Company Information
  3. 6.1.2 Emergent BioSolutions Business Overview
  4. 6.1.3 Emergent BioSolutions Human Bacterial Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Emergent BioSolutions Human Bacterial Vaccine Product Portfolio
  6. 6.1.5 Emergent BioSolutions Recent Developments
  7. 6.2 Mitsubishi Tanabe Pharma
  8. 6.2.1 Mitsubishi Tanabe Pharma Company Information
  9. 6.2.2 Mitsubishi Tanabe Pharma Business Overview
  10. 6.2.3 Mitsubishi Tanabe Pharma Human Bacterial Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Mitsubishi Tanabe Pharma Human Bacterial Vaccine Product Portfolio
  12. 6.2.5 Mitsubishi Tanabe Pharma Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Human Bacterial Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Human Bacterial Vaccine Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Human Bacterial Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GSK Human Bacterial Vaccine Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Human Bacterial Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Human Bacterial Vaccine Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Human Bacterial Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Merck Human Bacterial Vaccine Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Sanofi
  38. 6.7.1 Sanofi Company Information
  39. 6.7.2 Sanofi Business Overview
  40. 6.7.3 Sanofi Human Bacterial Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi Human Bacterial Vaccine Product Portfolio
  42. 6.7.5 Sanofi Recent Developments
7 North America
  1. 7.1 North America Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Human Bacterial Vaccine Market Size by Country (2021-2026)
  3. 7.3 North America Human Bacterial Vaccine Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Human Bacterial Vaccine Market Size by Country (2021-2026)
  3. 8.3 Europe Human Bacterial Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Human Bacterial Vaccine Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Human Bacterial Vaccine Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Human Bacterial Vaccine Market Size by Country (2021-2026)
  3. 10.3 South America Human Bacterial Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Human Bacterial Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Human Bacterial Vaccine Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Human Bacterial Vaccine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst